- Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancer
Moritz J. Reike et al, 2024, Cancer Epidemiology CrossRef - Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors
Fanfan Li et al, 2022, Frontiers in Immunology CrossRef - Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions
Eric J. Miller et al, 2023, Current Treatment Options in Oncology CrossRef - Gene expression of Nectin‐4 and its clinical significance in dogs with primary lung adenocarcinoma
Kei Tamura et al, 2022, Veterinary Medicine and Science CrossRef - An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma
G.Daniel Grass et al, 2023, European Urology Open Science CrossRef - Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker
Marcel Mayer et al, 2023, Clinical & Experimental Metastasis CrossRef - Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Zhiwen Fu et al, 2022, Signal Transduction and Targeted Therapy CrossRef - Antibody drug conjugates: The dos and don'ts in clinical development
Anthony W. Tolcher, 2022, Pharmacology & Therapeutics CrossRef - Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
Pierluigi De Santis et al, 2023, Journal of Clinical Medicine CrossRef - Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
Dylan Haynes et al, 2023, Human Pathology CrossRef - Arising Novel Agents in Lung Cancer: Are Bispecifics and ADCs the New Paradigm?
Amanda Reyes et al, 2023, Cancers CrossRef - Pembrolizumab plus enfortumab vedotin in urothelial cancer
Matteo Santoni et al, 2024, Nature Reviews Urology CrossRef - Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
Thomas Grinda et al, 2023, Current Treatment Options in Oncology CrossRef - Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin
Catherine C. Fahey et al, 2023, International Journal of Molecular Sciences CrossRef - Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
Florence Boissière-Michot et al, 2022, Frontiers in Immunology CrossRef - Gegen Nectin-4 gerichtete Antikörper-Wirkstoff-Konjugate als neue Behandlungsoption für Patienten mit metastasiertem Urothelkarzinom
Niklas Klümper et al, 2023, Die Urologie CrossRef - Antibody–Drug Conjugates in the Treatment of Urothelial Cancer
Avani M. Singh et al, 2023, BioDrugs CrossRef - Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review
Jakub Kobecki et al, 2022, Diagnostics CrossRef - LncRNA NORAD regulates the mechanism of the miR-532-3p/Nectin-4 axis in pancreatic cancer cell proliferation and angiogenesis
Kaiqiong Wang et al, 2023, Toxicology Research CrossRef